Core Points - The U.S. Food and Drug Administration (FDA) has issued a warning letter to Philips due to inspections revealing non-compliance with required manufacturing standards at three of its medical device facilities [1] Summary by Category Regulatory Actions - The FDA's warning letter indicates serious concerns regarding Philips' adherence to manufacturing standards, which could impact the company's operations and reputation in the medical device industry [1] Company Impact - Philips may face increased scrutiny and potential penalties as a result of the FDA's findings, which could affect its market position and investor confidence [1]